Therapix Biosciences Ltd.
TRPX
TRPX was delisted on the 1st of July, 2020.
7 hedge funds and large institutions have $312K invested in Therapix Biosciences Ltd. in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
2,736% more capital invested
Capital invested by funds: $11K → $312K (+$301K)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
75% more funds holding
Funds holding: 4 → 7 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$205K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.3K |
| 3 |
Millennium Management
New York
|
+$6.84K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$4.83K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$146 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $271K | +$205K | +424,656 | +3,682% |
|
|
2
UBS Group
Zurich,
Switzerland
| $26K | +$17.3K | +35,962 | +658% |
|
|
3
Millennium Management
New York
| $9K | +$6.84K | +14,200 | New |
|
|
4
Envestnet Asset Management
Chicago,
Illinois
| $6K | +$4.83K | +10,018 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$4K | -10,180 | Closed |
|
|
PCG
6
Private Capital Group
West Hartford,
Connecticut
| – | +$59 | +123 | New |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| – | +$146 | +302 | New |
|
TRPX Hedge Fund Activity: Q2 2020 in Review
7 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Therapix Biosciences Ltd. (TRPX) for Q2 2020, worth a combined $312K — up 2,736% from $11K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TRPX positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $205K. The largest seller was Citadel Advisors, exiting entirely with an estimated $4K sold.
- 7 institutional investors held Therapix Biosciences Ltd. (TRPX) as of Q2 2020, up from 4 in Q1 2020.
- Funds reported $312K of Therapix Biosciences Ltd. stock for Q2 2020, up 2,736% quarter-over-quarter.
- 4 funds opened new Therapix Biosciences Ltd. positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest Therapix Biosciences Ltd. buyer in Q2 2020 was Morgan Stanley, an estimated $205K added.
- The largest Therapix Biosciences Ltd. seller in Q2 2020 was Citadel Advisors, an estimated $4K sold.
Based on aggregated 13F filings for Q2 2020.